Company Valuation: Medicure Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 12.44 9.431 10.35 14.61 9.184 11.9
Change - -24.17% 9.78% 41.12% -37.14% 29.55%
Enterprise Value (EV) 1 11.17 6.906 6.346 8.786 2.867 8.953
Change - -38.16% -8.11% 38.45% -67.37% 212.3%
P/E -1.86x -13x 7.71x -15.6x -8.8x -1.68x
PBR 0.64x 0.51x 0.49x 0.73x 0.44x 0.92x
PEG - 0.1x -0x 0x -0.8x -0x
Capitalization / Revenue 1.07x 0.43x 0.45x 0.67x 0.42x 0.41x
EV / Revenue 0.96x 0.32x 0.28x 0.4x 0.13x 0.31x
EV / EBITDA -2.18x 19.1x 2.21x 9.42x -2.83x -1.77x
EV / EBIT -1.45x -2.77x 5.32x -10.3x -1.05x -1.3x
EV / FCF 2.66x 6.01x 4.87x 3.73x 5x 4.07x
FCF Yield 37.6% 16.6% 20.5% 26.8% 20% 24.6%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.6406 -0.0709 0.131 -0.09 -0.1 -0.68
Distribution rate - - - - - -
Net sales 1 11.61 21.74 23.06 21.69 21.91 28.86
EBITDA 1 -5.132 0.361 2.873 0.933 -1.014 -5.06
EBIT 1 -7.686 -2.495 1.193 -0.854 -2.737 -6.888
Net income 1 -6.845 -0.727 1.365 -0.922 -1.039 -7.097
Net Debt 1 -1.269 -2.525 -4.008 -5.825 -6.317 -2.944
Reference price 2 1.190 0.920 1.010 1.400 0.880 1.140
Nbr of stocks (in thousands) 10,451 10,251 10,251 10,436 10,436 10,436
Announcement Date 4/20/21 4/27/22 4/6/23 4/8/24 4/25/25 4/23/26
1CAD in Million2CAD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 9.7M
21.45x7.54x15.37x1.38% 72.12B
37.53x9.72x29.82x0.04% 65.85B
-18.08x7.59x-9.85x-.--% 29.28B
-79.5x14.86x-71.64x-.--% 27.47B
33.76x6.66x17.64x-.--% 26.7B
27.2x5.1x17.12x-.--% 20.06B
52.91x19.58x39.65x0.29% 18.22B
2460.33x41.28x-5047.29x-.--% 16.4B
16.73x4.96x11.58x-.--% 13.4B
Average 283.59x 13.03x -555.29x 0.19% 28.95B
Weighted average by Cap. 153.01x 11.04x -277.31x 0.37%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. MPH Stock
  4. Valuation Medicure Inc.